NIELSEN, Peter G.,THOMSEN, Mikael S.,HØJGAARD, Bent
申请号：
SG11201706899V
公开号：
SG11201706899VA
申请日:
2016.03.02
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity or an obesity associated disorder.
